Field evaluation in Thailand of spinosad, a larvicide derived from Saccharopolyspora spinosa (Actinomycetales) against Aedes aegypti (L.) larvae.

Two formulations of spinosad, direct application tablet (DT) and 0.5% granules (GR), at 3 dosages (0.25, 0.5 and 1.0 mg/l) in 200-liter earthen jars were evaluated against the larvae of Aedes aegypti. Two water regimens were used in the jars: jar full all the time and a full jar in which half the volume of the water was removed and replaced at each assessment interval. All treatments and controls were replicated 4 times and challenged with cohorts of 25 third-instar larvae of Ae. aegypti at weekly intervals during the study. The number of pupal skins (indicating successful emergence of adults) in the treated and control regimens were counted 7 days post-addition and they were used to calculate inhibition of emergence (% IE) based on the original number of larvae used. The DT formulation at the highest concentration (1.0 mg/l) yielded 79-100% IE for 34 days in the full jars, efficacy declining beyond this period. However, the longevity of this dosage was much longer with 90-100% IE for 62 days post-treatment in the water exchange regimen. The target and manufacturer-recommended concentration of 0.5 mg/l of DT gave good control (92-100% IE) for 20 days, declining below 92% IE thereafter in full jars. This dose also yielded good control with IE of 97-100% for 27 days in the water exchange regimen. The 0.5% GR formulation at all 3 dosages showed higher efficacy and greater longevity in the jars than the DT. In the full jars, all 3 dosages produced IE of 76-100% for 55 days post-treatment. In the water exchange regimen, the efficacy and longevity were increased by about one week, up to 62 days post-treatment. It is clear that the DT formulation can be used effectively against Ae. aegypti larvae at a target dose of 0.5 mg/l in 200-liter jars. This dose can be increased to 1.0 mg/l if slightly longer residual activity is desired. In containers where water is consumed and more water added, the longevity of efficacy will be longer for the DT than in jars which remain full all the time. GR (0.5%) gave longer control than DT. GR (0.5%) floated on the surface and produced scum and an oily film, features not desirable in stored water.

Larvicidal efficacy of new formulations of temephos in non-woven sachets against larvae of Aedes aegypti (L.) (Diptera: Culicidae) in water-storage containers.

Three new formulations of temephos (LAVIFOS SG 1%, MOSQ SG 1% and AZAI-SS ZG 1%) were evaluated for larvicidal efficacy against larvae of Aedes aegypti (L.) in water-storage jars under field-simulated conditions. LAVIFOS SG 1% and MOSQ SG 1% are sand granule formulations, whereas AZAI-SS ZG 1% is zeolite granule formulation. Each formulation contained 1% temephos as an active ingredient. Each formulation was packed in a non-woven sachet at quantity of 20 g per sachet and placed in a 200-liter glazed clay jar to obtain a dosage of 1 mg/l (one sachet per jar). Each treatment and control (jar without larvicide) was replicated four times. A concurrent set of treatments and controls were carried out in parallel, but the water in each treated and control jars was removed and refilled weekly. All jars (treatment and control) were challenged weekly by adding 25 third-instar larvae per jar and assessment was made of larval mortality by counting pupal skins one week after the addition of larvae. The three formulations provided complete larvicidal efficacy (100%) for at least 24 weeks post-treatment (the length of this study). In the jars where all the water was removed and refilled weekly, LAVIFOS SG 1%, and MOSQ SG 1% provided complete larvicidal efficacy for at least 24 weeks post-treatment, whereas AZAI-SS ZG 1% showed complete larvicidal efficacy for 16 weeks post-treatment. AZAI-SS ZG 1% still demonstrated a high degree of larvicidal activity (93-99%) from 17 to 24 weeks post-treatment. The present study reveals an excellent residual efficacy of the three new formulations of temephos against larvae of Aedes aegypti in water-storage jars lasting for at least 16 to 24 weeks post-treatment. These new formulations will make the control of DHF vectors in Thailand more cost effective as they are removable and retrievable sachets that can be reused after cleaning the water-storage containers.

Field evaluation of novaluron, a chitin synthesis inhibitor larvicide, against mosquito larvae in polluted water in urban areas of Bangkok, Thailand.

Novaluron, an insect growth regulator, a benzoylphenyl urea insecticide, was evaluated in the field against the larvae of polluted-water mosquitoes. The study was carried out in highly polluted sites infested with populations of mosquito larvae, mostly Culex quinquefasciatus Say, in low-income communities in urban areas of Bangkok, Thailand. An EC10 formulation was premixed in water and applied by pressurized spray tank to plots ranging from 180 to 1,000 m2 at the rate of 0.1 ml EC 10/m2 (equal to 10 mg a.i./m2) of the breeding sites. Assessments were made by sampling mosquito larvae and pupae to determine the trends of immature populations before treatment and weekly after treatment. Reduction of the populations in percents were then computed by comparing counts of immature mosquitoes (larvae and pupae) to the pretreatment counts at each particular site. It was found that the immature populations of mosquitoes in the treated areas were dramatically suppressed and remained at extremely low levels for 3-7 weeks after the treatment depending on the prevailing conditions of each experimental site. No negative impact on fishes or aquatic plants in the treated areas were detected during the study period and three months after the experiment was discontinued. Novaluron is an effective agent to control immature populations of polluted-water mosquitoes, especially Cx. quinquefasciatus in habitats in urban areas. This IGR larvicide may play an important role in vector control programs in terms of effectiveness, environmental friendliness and strategies for insecticide-resistance management in vector mosquitoes.

Simulated field evaluation of the efficacy of two formulations of diflubenzuron, a chitin synthesis inhibitor against larvae of Aedes aegypti (L.) (Diptera: Culicidae) in water-storage containers.

Tablet (40 mg a.i./tablet) and granular (2% a.i.) formulations of diflubenzuron, a chitin synthesis inhibitor, insect growth regulator, were evaluated for larvicidal efficacy against the larvae of Aedes aegypti (L.) in water-storage containers under field conditions in Thailand. Each formulation was applied to 200-1 clay jars at 5 different dosages (0.02, 0.05, 0.1, 0.5 and 1 mg/l a.i.). The jars were covered with solid celocrete sheets and placed in the shade under a roof. Another experiment was also carried out using 3 different dosages (0.1, 0.5 and 1 mg/l) where half the water in each treated jar and the control was removed and refilled weekly. Each treatment was replicated four times. The treatments were challenged by adding 25 3rd instar larvae/jar weekly. Assessments were made of each treatment through emergence inhibition (%EI) by removing and counting pupal skins one week after larval addition. Using these assessment techniques, a high degree of larvicidal efficacy (96-100%EI) was achieved with 4 dosages (0.05, 0.1, 0.5 and 1 mg/l) of both (tablet and granular) formulations for a period of 23 weeks post-treatment. The efficacy of the lowest dosage (0.02 mg/l) of tablet and granular formulations lasted for 21 and 22 weeks post-treatment, respectively. Under the conditions of water removal and weekly refilling, a high degree of larvicidal efficacy (96-100%El) at the 3 dosages was obtained with the tablet formulation 18 to 21 weeks post-treatment, whereas the efficacy of the granular formulation persisted 15 to 23 weeks post-treatment depending on the dosage. This study clearly demonstrates a high level of residual activity with both formulations of diflubenzuron against larvae of Ae. aegypti in water-storage containers. Considering environmental factors and water-use conditions, it is likely that dosages of 0.05 to 0.1 mg a.i./l are effective dosages providing long-lasting control for 3 to 4 months in the field.

Repellency of essential oils extracted from plants in Thailand against four mosquito vectors (Diptera: Culicidae) and oviposition deterrent effects against Aedes aegypti (Diptera: Culicidae).

In this study we evaluated and reported repellent effects of essential oils from Thai plants against 4 mosquito vectors: Aedes aegypti, Ae. albopictus, Anopheles. dirus and Culex quinquefasciatus under laboratory conditions using human volunteers. The essential oils were extracted from 18 plant species, belonging to 11 families, and the oils were then prepared as 10% solution in absolute ethanol with additives. Two chemical repellents, deet and IR3535, were also prepared in the same formulation as the essential oil repellents and tested for repellency as controls. The essential oils were also evaluated for oviposition deterrent effects against Ae. aegypti under laboratory conditions. The results show night-biting mosquitoes (An. dirus and Cx. quinquefasciatus) and Ae. albopictus were more sensitive to all the essential oils (repellency 4.5 - 8 hours) than was Ae. aegypti (repellency 0.3 - 2.8 hours), whereas deet and IR3535 provided excellent repellency against all four mosquito species (repellency 6.7- 8 hours). All essential oils exhibited oviposition deterrent activity against Ae. aegypti with various degrees of repellency ranging from 16.6 to 94.7%, whereas deet and IR3535 had no repellency. The present study demonstrates the potential for using essential oils as mosquito repellents and oviposition deterrents. These findings may lead to new and more effective strategies for protection from and control of mosquitoes.

Double infection of heteroserotypes of dengue viruses in field populations of Aedes aegypti and Aedes albopictus (Diptera: Culicidae) and serological features of dengue viruses found in patients in southern Thailand.

In order to understand more about the epidemiology of DHF, a study of the type of dengue viruses and vectors under natural conditions was carried out. Mosquito vectors in the field and the serum of DHF patients in southern Thailand were examined. The two mosquito species are abundant and DHF incidence remains high in this region. Dengue viruses were examined in field-caught mosquitoes by RT-PCR technique. The mosquitoes were caught in 4 provinces: Krabi, Phuket, Phang-Nga and Surat Thani during the late dry season until the early rainy season in 2005. Three dengue serotypes (DEN-2, DEN-3, DEN-4) were detected in Ae. aegypti males and females, and 2 (DEN-2, DEN-3) were detected in Ae. albopictus females. Double infection with 2 serotypes of dengue viruses (DEN-2 and DEN-3) were detected in Ae. aegypti males and females and Ae. albopictus females. DEN-2 and DEN-1 were the most prevalent serotypes found in the serum of the patients in this area, followed by DEN-4 and DEN-3. The prevalence of the predominant dengue serotype varied from province to province. Detection of viruses in adult male mosquitoes reveals the role of transovarial transmission of dengue viruses in field populations of DHF vectors and elucidates circulation of dengue viruses in vectors in the natural environment of endemic areas. The incidence of multiple serotypes of dengue virus in Ae. aegypti and Ae. albopictus in the same area points toward a high risk for an epidemic of DHF. These findings provide greater understanding of the relationship among mosquito vectors, virus transmission and DHF epidemiology in endemic areas.